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B-1 Cell Heterogeneity and the 
Regulation of Natural and  
Antigen-induced igM Production
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Davis, CA, USA
A small subset of B cells, termed B-1 cells, with developmental origins, phenotypes, and 
functions that are distinct from those of conventional B cells exist in mice. It contributes 
the vast majority of spontaneously produced “natural” IgM. Natural IgM is constitutively 
produced, even in the absence of microbiota, and fulfills many distinct functions in tissue 
homeostasis and host defense. B-1 cells also respond with IgM production to innate 
signals and pathogen exposure, while maintaining steady-state levels natural IgM. Thus, 
within the B-1 cell pool, cells of distinct and heterogeneous functionality must exist to 
facilitate these different functions. This review considers three factors that may contrib-
ute to this heterogeneity: first, developmental differences regarding the origins of the 
precursors, second, tissue-specific signals that may differentially affect B-1 cells in the 
tissue compartments, and finally responsiveness to self-antigens as well as innate and 
antigen-specific signals. All three are likely to shape the repertoire and responsiveness 
of B-1 cells to homeostatic- and antigen-induced signals and thus contribute to the 
functional heterogeneity among these innate-like B cells.
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iNTRODUCTiON
The B cell compartment of all jawed vertebrates contains populations of spontaneous “natural” 
Ig-secreting cells (1). These antibodies are broadly self-reactive and most are of the IgM isotype. 
The best-studied natural antibody-producing cell population is that of mice, in which a subset of 
CD5-expressing B cells, CD5 was thought of until then as a T cell-restricted surface receptor, was 
linked to natural IgM production (2). Further studies showed differences in B-1 cell development 
origins, tissue distribution, and responsiveness to antigens and mitogens compared with classical fol-
licular B cells and thus identified them as distinct from the majority “conventional” B cell population 
[reviewed in Ref. (3, 4)]. Because these cells appear earlier in ontogeny than conventional B cells, they 
were termed “B-1 cells” and conventional B cells “B-2 cells”; CD5 expression is used to differentiate 
B-1 cells further into B-1a (CD5+) and B-1b (CD5−).
Numerous groups demonstrated that in addition to generating natural antibodies, B-1 cells also 
actively contribute to pathogen-induced immune responses (2). Explored have been responses to 
Francisella spp (5, 6), Borrelia hermsii (7–9), Salmonella typhi (10, 11), Streptococcus pneumoniae 
(12–14), and influenza virus (15–17). In each case, the response consisted of increased B-1 cell-
derived IgM production, measured in regional lymph nodes, the spleen, and/or in serum. This raises 
important questions about the regulation of natural versus antigen-induced antibody production by 
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B-1 cells. Studies on influenza virus infection showed that despite 
an increased local production of B-1 cell-derived IgM, natural 
serum IgM levels remained unaffected (15), suggesting the 
presence of distinct subsets of B-1 cells that contribute systemic 
natural and enhanced infection-induced local IgM production, 
respectively.
At least two non-mutually exclusive models may explain these 
observations: a “division of labor” model, as proposed (14), in 
which distinct B-1 cell subsets exist, some responsible for natural 
antibody production. In the studies by Haas et  al., B-1b cells 
responded to S. pneumoniae antigens by making antibodies, 
whereas B-1a cells constitutively produced natural IgM antibod-
ies against other components of S. pneumoniae. However, given 
that in other infections (see below), B-1a cells were also shown to 
respond with increased antibody production, a simple division of 
labor between B-1a and B-1b seems unlikely. Another model is 
that the degree of self-antigen-mediated stimulation of the BCR 
and/or additional costimulatory signals may support a certain 
number of B-1 cells to differentiate to natural antibody-producing 
cells, while others remain quiescent, until stimulation by innate 
signals and/or antigen exposure activates these cells above a 
certain threshold required for their differentiation. Common to 
both models is the idea that the B-1 cell pool contains B-1 cells of 
different functional properties.
The literature supports the notion of a heterogeneous B-1 cell 
pool, but the causes for this heterogeneity are largely unknown 
and little explored. Below, we consider three factors that may 
modulate B-1 cell functions: (1) the multiple developmental 
origins of B-1 cells, (2) tissue-specific signals, and (3) differences 
in exposure to and responsiveness of B-1 cells to self- and foreign 
antigens. Determining the relative impact of these signals on the 
functionality of B-1 cells could clarify much of the biology of this 
cell population and of one of its important products: natural IgM.
MULTiPLe DeveLOPMeNTAL ORiGiNS 
CONTRiBUTe TO THe B-1 CeLL POOL
Early studies demonstrated that B cell precursors exist in the 
splanchnopleura of the developing mouse embryo, which give 
rise only to B-1 but not B-2 cells, but the precursors were not 
identified (18). More recent reports supported these findings by 
showing that the earliest B-1 cells arise from extra-hematopoietic 
sources, the blood island cells of the yolk sac (19, 20), similar to 
the development of some macrophage populations (21). In 2006, 
Montecino-Rodriguez et  al. identified B cell precursors in fetal 
liver and in small numbers also in the bone marrow of adult mice 
that give rise only to B-1 cells (22). These B-1 cell-restricted pre-
cursors (pre–pro-B) among otherwise “lineage negative cells” were 
differentiated from early conventional (B-2) cell precursors by 
their lack of CD45R (B220) and strong expression of CD19. While 
present also in the adult bone marrow, it was further reported that 
by 3–6 weeks after birth, B-1 cell precursors are no longer contrib-
uting significantly to the adult B-1 cell pool (23), consistent with 
a previous body of literature that showed B-1 cells to be a mainly 
fetal- and neonatal-developed population that is maintained by 
self-renewal rather than de novo development (24, 25).
It appears that the bone marrow precursors can be activated 
in situations of severe lymphopenia, however, as occurs follow-
ing adoptive cell transfer of bone marrow into lethally irradiated 
recipients (26, 27). In that situation, the emerging B-1 cell popu-
lations are much more heavily skewed toward CD5− B-1b cell 
development. The reasons for this remain to be explored. Thus, 
existing data support the concept that the CD5+ B-1a cell pool 
is largely, albeit not exclusively, fetal and neonatal derived (28). 
This conclusion was recently further underscored by the demon-
stration of a developmental switch between fetal and post-natal 
development, regulated by the transcription factor Lin28b that 
significantly affected B-1 cells (29, 30). The studies showed that 
the expression of Lin28b induces a regulatory network of tran-
scriptional regulators that support the development of B-1a cells. 
In its absence, B-1a cell populations are greatly reduced, while 
forced overexpression of Lin28b in adult bone marrow precursors 
enhances B-1a cell output in adulthood (29, 30). In the latter case, 
BCR repertoire differences compared with B-1a cells generated 
from fetal precursors were noted (30), however, suggesting that 
other signals regulate development and/or selection of these cells.
The lack of sustained de novo B-1 cells development beginning 
from a few weeks after birth was first demonstrated by Lalor et al. 
(25). It can be exploited experimentally by transferring peritoneal 
cavity-derived B-1 cells into neonatal mice rendered B cell-
deficient by allotype-specific anti-IgM antibody treatment (24, 
31). Once recipient mice reach 6 weeks of age, discontinuation of 
antibody treatment will lead to the reemergence of bone marrow-
derived B-2 cell populations, but only few B-1 cells. In that man-
ner, one can generate chimeras in which B-1 cells and their Ig are 
marked by allotype, or lack or express certain genes only in one 
of the B cell compartments. Given that B-1 cells are maintained 
throughout life by self-renewal, i.e., continuous turnover, it will 
be important to explore the effects of aging on their functionality. 
Indeed, recent studies suggest alterations to these populations in 
the aging animals (32). Whether this affects primarily the pro-
duction of natural IgM, antigen-induced responses of B-1 cells, 
or both will be an important future target for study.
Thus, the B-1 cell pool of adult mice is likely shaped by distinct 
waves of B-1 cells that develop from distinct precursors: the first 
wave of extra-hematopoietic yolk sac B-1 precursors that popu-
late the fetal liver until about E15.5; the second wave of fetal liver 
precursors that presumably dominates the B-1 cell pool at birth; 
and the third set in the bone marrow that gives rise to B-1 cells 
developing during the first few weeks of life (33). All waves are 
expected to modulate the B-1 cell pool. An unanswered question 
is to what extent these distinct waves generate B-1 cells of differ-
ent repertoires, tissue distribution, functionality, and/or lifespan.
Natural igM Regulates B Cell Development
Recently, we demonstrated that mice unable to generate secreted 
(s)IgM contain few B-1 cells in the body cavities, while spleen and 
bone marrow B-1 cell populations appeared largely unchanged 
(34). B-2 cell development was also significantly affected. These 
studies were in apparent contrast to earlier reports that suggested 
the presence of increased B-1 cell frequencies in the peritoneal 
cavity of sIgM−/− mice (35, 36), which usually make about 
60% of B cells at that site. The discrepancy is explained by our 
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findings that these mice harbor large numbers of anergic, CD5+ 
conventional B cells in both spleen and peritoneal cavity, which 
due to their expression of CD5 were misidentified as B-1a cells. 
These anergic CD5+ B cells are distinct, however, in that they are 
CD19int, B220hi, and CD43−, in contrast to the CD19hi, B220lo, and 
CD43+ B-1a cells (34).
Approximately 1.5–2% of B cells in the spleen of commonly 
used inbred mouse strains are B-1 cells (37). Interestingly, asplenic 
Hox11−/− mice were shown previously to have reduced numbers 
of peritoneal cavity B-1 cells (38) and splenectomy resulted in a 
reduction of already established peritoneal cavity B-1a cell pools 
over time (38, 39). Since the spleen is an important tissue source 
of natural IgM (40, 41) and the Hox11−/− mice showed reductions 
in serum IgM levels (38), it is unclear whether there is a precur-
sor–offspring relationship between spleen and peritoneal cavity 
B-1 cells or whether the reductions in sIgM indirectly affected B-1 
cell development/expansion.
Our findings, demonstrating alterations in B-2 cell develop-
ment as early as the bone marrow pre-B cell stage when mice lack 
secreted IgM, are difficult to reconcile with previous suggestions 
that the B cell defects seen in the absence of natural IgM are due 
to lack of apoptotic cell clearance and other “housekeeping func-
tions” attributed to IgM (36, 42). While this could explain the 
emergence of autoreactive, including anergic, B cells, it is hard to 
see how this would affect pre-B cell selection. Furthermore, mice 
that lack the Fc receptor for IgM (FcμR) have about twice the 
amount of natural serum IgM, yet they develop autoantibodies 
similar to sIgM−/− mice (43). Based on these and other findings, 
we suggest that natural IgM regulates B cell development by func-
tions that are independent of its role in the removal of cell debris 
and autoantigens, but rather by yet to be discovered mechanisms 
that directly regulate B cell development.
Irrespective of the mechanisms, the findings of a dependency 
of normal B cell development on natural IgM indicates that the 
earliest waves of B-1 cells produces the natural IgM that allows 
normal B-1 and B-2 cell development to commence. The fact that 
peritoneal cavity B-1 cells, but not splenic B-1 cells, are affected 
by the lack of IgM further suggests that peritoneal cavity B-1 cells 
development is dependent on distinct signals and may occur later, 
after natural IgM production has been initiated in the murine 
fetus, as IgM, in contrast to IgG, does not effectively cross the 
placenta (44, 45). Indeed, while small numbers of B-1 cells, 
including IgM-secreting cells, are detectable before birth in the 
fetal liver and at birth in the mouse spleen, peritoneal cavity B-1 
cells accumulate slowly and not until about 1–2 weeks after birth 
and the accumulation of B-1 cells in peritoneal and pleural cavity, 
but not the spleen, are dependent on secretion of the “follicular” 
homing chemokine CXCL13 (46).
Repertoire Development of Spleen and 
Body Cavity B-1 Cells
It is of note that the repertoire of B-1a cells in the peritoneal cavity 
is distinct from that of the spleen. This is exemplified by measur-
ing frequencies of B-1a cells that bind to liposomes containing 
phosphotidyl choline (PtC) by FACS, many of which are encoded 
by IgHV11 (47). While the splenic compartment harbors only 
about 1–2% of PtC binders among B-1a cells, that frequency is 
approximately 10% in the peritoneal cavity (48). In mice lacking 
sIgM, frequencies of PtC binders in the peritoneal cavity and 
mRNA for IgHV11 are greatly diminished (34), suggesting that 
B-1a cells with that specificity emerge (or expand) later and then 
preferentially home to the body cavities.
A recent comprehensive RNA sequencing study on pooled 
RNA from FACS-purified B-1a and B-2 cells in spleen and peri-
toneal cavity at various ages of mice further supported previous 
findings of a B-1 cell B cell receptor (BCR) repertoire that is 
clearly distinct from that of the B-2 cell pool (49). The B-1 cell 
repertoire is enriched for self-reactivity, and there is a preponder-
ance of Ig-regions that lack N-region insertions, again supporting 
the conclusion that B-1 cells are generated before birth, when the 
enzyme TdT is not yet expressed, and thus does not facilitate 
inclusions of N-regions during V-D-J recombination. However, 
both earlier single-cell PCR experiments (50, 51) and the more 
recent studies (32, 49) demonstrated that the repertoire of B-1a 
cells is broader, more diverse and not as devoid of N-region inser-
tions as originally anticipated.
The recent B-1a cell repertoire studies support earlier conclu-
sions, which had suggested that the repertoire of the B-1a cell 
pool is unaffected by foreign antigen exposure. Germ-free mice 
were shown to have a similar B-1a cell repertoire than that of mice 
held under SPF housing conditions (49). Similarly, germ-free 
mice have similar levels of natural IgM and numbers of natural 
IgM-producing cells in spleen and bone marrow than SPF mice 
(40). This is not, however, because natural IgM production or the 
B-1a cell pools are already fully developed at birth. Neonatal mice 
have very few IgM-secreting cells, few B-1 cells and their serum 
IgM levels increase dramatically during the first few weeks of life. 
This was shown already in the 1970s, when early studies dem-
onstrated that antibody-producing cells specific for phosphoryl 
choline encoded by the T15 idiotype, later found to be expressed 
nearly exclusively by B-1a cells, did not appear in the spleen and 
bone marrow until about 1 week after birth and were absent from 
the fetal liver (52, 53). Frequencies of these antigen-specific cells, 
while varying in size between individual mice, were present at 
overall similar frequencies in germ-free and conventionally 
housed animals, and the pool size was independent of the geno-
type of the mothers. Similarly, Yang and colleagues noted that the 
repertoire of B-1a cells in fetal liver and at birth differed from that 
of B-1a cells in both peritoneal cavity and spleen at weaning and 
in adulthood (49). Thus, B-1a cells and natural IgM titers undergo 
dramatic expansions and changes during the first few weeks after 
birth. While this timing coincides with the first exposure to 
microbiota and other environmental antigens, the similarities in 
B-1a cell BCR repertoires between gnotobiotic and SPF-housed 
mice suggest that this repertoire and the production of natural 
IgM are regulated in ontogeny, at least in part, by age-specific 
factors, which could include the emergence of, or exposure to, 
other cell types, and/or self-antigens.
Modulating the Pool of Natural  
igM-Secreting Cells
In apparent contrast to these findings, early studies demonstrated 
that B-1 cells can respond to α1–3 dextran (54). More recent 
studies by Kearney and colleagues have provided evidence that 
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injection of polysaccharides found on the facultative pathogen, 
Aspergillus fumigatus, as well as on house dust mites, permanently 
altered the natural IgM repertoire when given during a brief win-
dow of development just after birth [summarized in Ref. (55)]. 
While they could not detect significant changes in serum IgM 
levels, consistent with a body of work demonstrating the inability 
of newborns to respond to T-independent antigens, their data 
suggested instead that permanent changes occur affecting 
the repertoire of polysaccharide-specific B cells. They further 
demonstrated that this allowed mice to respond to subsequent 
antigen exposure more robustly with antibody production and 
a shift away from harmful allergic humoral responses to sup-
port immune protective responses (56, 57). These studies are of 
significance as they further underscore the crucial effects of IgM 
on the maintenance of tissue and immune homeostasis. They 
also provide a potential link to and mechanism in support of the 
“hygiene hypothesis,” which predicts that exposure to pathogens, 
at an early age, may prime the immune system in such a way that 
development of allergic reactions are less likely (55).
Apart from the semantic argument of whether IgM antibodies 
induced in response to foreign antigen exposure/vaccination 
should still be considered “natural antibodies,” the more impor-
tant question is why such foreign antigen-induced changes do not 
seem to affect the BCR repertoire of B-1a cells. Potential explana-
tions are that these antigen-stimulated cells do not arise from the 
stimulation of B-1 cells, or that following antigen exposure these 
cells change their phenotype such that they are no longer detect-
able as part of the “B-1a cell pool.” It will be of interest to study the 
emerging antigen-specific B cells in greater detail.
TiSSUe-SPeCiFiC SiGNALS AS 
MODULATORS OF B-1 CeLL FUNCTiONS
Adoptive transfer of adult-derived peritoneal cavity B-1 cells into 
newborn mice seeds all major B-1 cell niches in spleen, body 
cavities, and bone marrow, such that frequencies of B-1 cells and 
the antibody-producing cells, and natural serum IgM levels, are at 
normal levels compared with non-manipulated mice (24, 41, 54). 
This includes reconstitution of the recently described population 
of IgM plasma cells in the bone marrow [Ref. (58); Savage et al., 
under review1], demonstrating their B-1 cell origins. This is quite 
remarkable, given the functional differences of B-1 cells in perito-
neal and pleural cavity versus the spleen, as well as their extensive 
gene expression differences. It is also in apparent contrast to the 
above data regarding the differential developmental requirements 
of spleen and body cavity B-1 cells.
It is possible that B-1 cell populations in the body cavities 
are heterogeneous, containing distinct B-1 cell subsets that will 
seed the spleen, bone marrow, or body cavities, respectively. 
Alternatively, B-1 cells are homogenous but have the plasticity 
to adapt to tissue-specific signals that induce the phenotypic 
and functional alterations between B-1 cells in these different 
1 Savage, H.P., Yenson, V.M., and Baumgarth, N. (2016). Blimp-1 dependent and 
independent production of natural Ig by B-1 cells and B-1-derived plasma cells. 
submitted.
locations. Overall, scientific evidence to date seems to support the 
latter. Weiss and colleagues attempted to address this question by 
adoptively transferring peritoneal cavity B-1 cells and then meas-
uring expression of a handful of genes they had identified as being 
differentially expressed by spleen and peritoneal cavity B-1 cells 
(59). Their data showed that the gene expression profile of the 
donor cells was dependent on their tissue location and not their 
tissue of origin, thus supporting the idea of tissue-specific signals 
modulating the gene expression profile of the transferred B-1 
cells. However, single-cell transfer or fate-mapping approaches 
would be necessary to formally rule out that this is due to cell 
selection rather than tissue-induced changes.
One long known tissue-induced difference between B-1 cells 
in body cavity and spleen is their differential expression of the β-2 
integrin CD11b. While most peritoneal cavity B-1 cells express 
CD11b, the integrin appears to be lost rapidly after B-1 cell leave 
the body cavities and enter lymphoid tissues. The small number 
of CD11b− B-1 cells in the body cavities appears to identify 
recent arrivals to that site [reviewed in Ref. (4)]. While the tissue-
specific signals that induce expression of CD11b on B-1 cells in 
the body cavities are unknown, we recently demonstrated one of 
its functions. Specifically, we showed that CD11b was required 
for effective homing of B-1a cells from body cavities to draining 
lymph nodes after infection (60). The lack of CD11b did not affect 
the emigration of B-1a cells from the body cavities. Instead, it 
was required for the enhanced accumulation of B-1a cells to the 
lymph nodes. Given that B-1a cells rapidly lose CD11b expres-
sion upon entering secondary lymphoid tissues, it appears that 
the interaction of CD11b with its ligand enhances the entrance 
of B-1a cells from the blood or lymphatic vessels into the lymph 
tissue. Thus, CD11b expression by B-1 cells is actively modulated 
by tissue-specific and/or inflammatory signals.
The abovementioned repertoire differences in BCR expression 
between B-1 cells in spleen and body cavity may also suggest 
the presence of tissue-specific factors that drive B-1 cell clonal 
expansion and/or selection. In the absence of obvious effects of 
the microbiota on these changes, tissue-restricted expression of 
autoantigens may account for the distinct repertoires of B-1 cells 
in different sites. However, this would then also suggest that the 
B-1 cell compartments of spleen, bone marrow, and body cavity 
do not usually interchange much. Yet, when we measured the 
migration of B-1 cells from the body cavity to other tissues, we 
found that labeled B-1 cells (labeled either with radioisotopes or 
fluorescent dyes) rapidly disappeared from these sites and then be 
found in the blood, indicating that there is continuous circulation 
of body cavity B-1 cells (60).
Another well explored difference between B-1 cells in body 
cavities and spleen/bone marrow is the fact that spontaneous 
“natural” IgM production is largely restricted to cells in spleen 
and bone marrow (41). An earlier study suggested that body 
cavity macrophages suppress B-1 cell antibody production via 
production of prostaglandin (61). Indeed, isolation of B-1 cells 
often leads to a larger production of IgM in vitro, than culturing 
cells in the context of the entire cell populations found in the cavi-
ties (41). That data fit well with the lack of spontaneous antibody 
production by B-1 cells in the body cavities and the fact that in 
response to stimulation, body cavity B-1 cells rapidly migrate to 
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the environments of the spleen and lymph nodes, where they 
begin to secrete antibodies in response to innate and possibly 
antigen-specific stimulatory signals (5, 17, 60, 62–65).
Finally, early studies by Kroese and colleagues demonstrated 
that nearly half of the IgA-secreting plasma cells in the gut are 
B-1 cell derived (66, 67). Using allotype-chimeric mice similar 
to studies described by Kroese et al., we found that in the lung of 
young adult BALB/c mice about one-third of IgA-expressing cells 
to be B-1 cells (Baumgarth, unpublished)2. Based on in vitro and 
in vivo studies, it appears that B-1 cells like their B-2 counterparts 
require TGFβ-signaling for class-switch recombination to IgA, as 
TGFβ receptor-deficient mice are devoid of all IgA production 
(68). It is possible that activation of CD11b on peritoneal cavity 
B-1 cells drives their accumulation in the mesenteric lymph nodes 
in a manner similar to the activation described by us for B-1 cells 
from the pleural cavity and their migration to the mediastinal 
lymph nodes of the lung (60).
While many questions remain, overall there is strong evidence 
that the tissue environment contributes to the distinct phenotypes 
and functions of B-1 cells in each tissue compartment.
B-1 CeLL ReSPONSiveNeSS TO  
SeLF- AND FOReiGN ANTiGeNS
B-1 Cell Responses to Foreign Antigens
The removal of tissue (body cavity)-specific inhibitory signals as 
a mechanism of regulation for B-1 cell antibody production is an 
attractive solution to the conundrum of B-1a cell response regula-
tion, a cell that appears unable to respond to anti-IgM induced 
BCR cross-linking with proliferation or IgM production in vitro 
(69), yet seems to undergo at least limited clonal expansion in 
response to some antigen-specific signals in  vivo (see above). 
However, this unlikely comprises the entire regulatory network 
controlling B-1 cell activation. Other signals that are known to 
induce B-1 cell activation include cytokines, specifically IL-5 and 
IL-10 (70). Lack of IL-5 or its receptor reduces B-1 cell numbers 
and natural IgM levels in mice (71, 72), including the levels of 
the classical T15 idiotype-expressing IgM, which binds oxidized 
low-density lipoproteins and pneumococcal polysaccharides 
(73). Overexpression of IL-5 in vivo (74, 75), exposure of B-1 cells 
to IL-5 in vitro, and injection of IL-5 into the peritoneal cavity 
in vivo induce secretion of IgM following the migration of B-1 
cells to the spleen (70).
Consistent with the role of body cavity B-1 cells as surveyors 
of organ system health and rapid responders to an infection, 
injection of LPS (76), or bacteria (65) into the peritoneal cav-
ity induces their rapid migration to lymph tissues, where they 
differentiate to antibody-producing cells. Activation of B-1 cells 
in the latter case was shown to be dependent on the innate signal-
ing adaptor MyD88 (65) and thus appears mediated by innate 
rather than antigen-specific B-1 cell stimuli. Similarly, following 
respiratory tract infection of mice with influenza infection, we 
noted a rapid drop of B-1a, but not B-1b cells, in the pleural 
cavity and a concomitant accumulation of these cells in the 
2 Baumgarth, N. (2016). Unpublished observation.
regional lymph nodes of the respiratory tract (60). The enhanced 
infection-induced accumulation, but not the migration itself, 
was dependent on direct signaling via the type I IFNR by pleural 
cavity B-1a cells. Type I IFNR signaling was shown to activate the 
β-2 integrin CD11b to a high-affinity state, which can bind its 
ligands and thereby mediate the transfer of B-1 cells across the 
endothelium (60).
Importantly, in the latter case, the frequency of influenza-
binding B-1 cells among those accumulating in the lymph nodes 
was not significantly different from those in the spleen before 
influenza infection (17). Also, B-1a cells that accumulated in 
the lymph nodes did not incorporate significant levels of BrDU, 
suggesting that these cells responded to influenza infection by 
relocation and IgM production in an antigen non-specific man-
ner, rather than clonal expansion (17). Yet, following application 
of non-mitogenic LPS from Francisella tularensis, modest expan-
sion of antigen-specific B-1a cells and even formation of memory 
B cells seemed to occur (5, 6), suggesting that the lack of B-1a cell 
expansion is not absolute and also depend on the type of antigen.
While responses to both influenza virus infection and non-
mitogenic LPS from F. tularensis were shown to primarily activate 
B-1a cells (5), infections with B. hermsii (7), S. pneumonia (14), 
and Salmonella (10, 11) were shown to stimulate predominantly 
or exclusively B-1b. In response to infection with Borrelia burg-
dorferi, we found neither B-1a nor B-1b cells to respond in any 
significant fashion (Hastey et  al., in preparation)3. What deter-
mines this differential responsiveness to antigens and pathogens 
is unexplored. Possible explanations include the BCR repertoire 
(50, 51, 77), i.e., differential antigen-specificity among each B cell 
subset, the site of infection/injection, the quality of the induced 
innate responses, or other factors. Addressing this question will 
be important to gain a more complete understanding of the 
signals that induce B-1 cell responses.
B-1 Cells and Self-Antigen Recognition
A final consideration for regulation of IgM production by B-1 
cells is their responsiveness to self-antigens. Elegant studies by 
Hayakawa and colleagues demonstrated that the lack of self-
antigen expression (in that case the T cell-expressed antigen 
“Thy-1”) caused a failure to develop self-reactive B-1a cells to 
that specificity (78), usually a normal component of the B-1a cell 
repertoire of wild-type mice (79). This data provided the strong-
est evidence to date that the B-1a cell repertoire is selected for 
binding to self. Consistent with a positive selection event being 
necessary for the development of B-1a cells are data indicating 
that signals that enhance BCR-signaling usually cause increased 
B-1 cell pools, while mutations reducing BCR-signaling reduce 
such pools. Examples are deficiencies in the coreceptor CD19 or 
signaling molecule Btk, causing reduction of B-1a cell numbers, 
and deficiencies in coinhibitory molecules, such as CD72 increas-
ing these pools [summarized in Ref. (3)]. Thus, positive selection 
and BCR-signaling appear to be critical elements of B-1a cell 
development. This is consistent with the resulting B-1 repertoire, 
3 Hastey, C. J., Elsner, R. A., Olsen, K. J., Tunev, S. S., Escobar, E. D., Barthold, S. W., 
et al. (2016). Borrelia burgdorferi infection induced-IgM controls bacteremia but 
not bacterial dissemination or tissue burden. in preparation.
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which is clearly skewed toward the recognition of self-molecules; 
particularly those expressed when tissues are altered, stressed, 
or senescent. Examples are oxidized low-density lipoproteins 
and antigens expressed by dead and dying cells. The binding of 
natural IgM to such antigens is thought to fulfill “housekeeping” 
functions by opsonizing these antigens for removal by phagocytic 
cells, such as macrophages, while avoiding or actively inhibiting 
inflammation (80). In certain disease states, however, the genera-
tion or accumulation of these antibodies correlates with disease. 
A prominent example is reperfusion injury, where the binding of 
natural IgM to tissues stressed or damaged by hypoxia following 
blood flow disruption is thought to activate the complement 
cascade and cause tissue injury (81–83).
The recently published comprehensive repertoire analysis 
conducted on B-1a cells confirmed and expanded previous 
studies, which together showed differences in the B-1a repertoire 
based on the age of the host (49). The study by Yang and col-
leagues reported quite dramatic alterations in the repertoire of 
spleen and peritoneal cavity B-1a cells, driven by the strong and 
unequal expansion of certain clones, right after weaning (3 weeks 
of age) (49). Since alterations in the microbiota were excluded as 
a potential cause, because similar changes were observed also in 
gnotobiotic mice, the data might suggest that alterations in, or 
exposure to certain self-antigens could be causing these repertoire 
shifts. However, other causes cannot be ruled out, in particular 
the potential influence of food antigens. The timing of these 
repertoire changes appears to occur later than the time window 
identified by Kearney and colleagues by which the B-1 repertoire 
to certain polysaccharides is amenable to change (55). The fact 
that B-1 cells have a phenotype similar to activated cells: they 
express CD43, lack expression of CD23, and have low expression 
of CD45R (B220) and IgD, could further support the idea that 
their arrival in the peritoneal cavity and clonal outgrowth is the 
result of encounter with self-antigens.
Natural igM Production and B-1 Cell 
Repertoires Are independently Regulated
It is important to distinguish between changes in the repertoire 
of the overall B-1 cell pool and the extent to which these changes 
affect the repertoire of the natural IgM-producing cells and thus 
the serum IgM specificities. Natural IgM-producing cells are dis-
tinct from peritoneal cavity B-1 cells and represent only a small 
subset of B-1 cells in the spleen, currently not distinguishable 
from non-secreting cells with surface markers. Although a small 
subset of CD19+ CD43+ B-1 cells expresses CD138 (84), these 
are not the major natural IgM producers in the spleen (Savage 
et al., under review)1. Therefore, it should not be assumed that 
the identified repertoire shifts within the B-1a cell pool neces-
sarily affect the specificity of the secreted natural IgM. It will 
be important to identify and characterize the B-1 cell-derived 
natural IgM-producing cells in ontogeny and to compare their 
repertoire to that of the non-secreting B-1 cells.
The extent to which the secreted antibody repertoire is affected 
by age and/or antigen exposure is an important question, as this 
could have implication for immune defense and tissue homeosta-
sis. Indeed, Holodick and colleagues recently provided evidence 
that IgG-depleted serum from very old mice lost its protective 
capacity for protection from S. pneumoniae infection compared 
with the same serum preparation from young mice (32). Thus, 
indicating that both B-1a cell repertoires and secreted IgM 
repertoires, or their effector functions, can shift with age. What 
underlies such shifts remains unresolved, given that much of the 
B-1 cell pool is maintained mainly through self-renewal rather 
than de novo development of B-1 cells, with bone marrow output 
although not completely abrogated, rather greatly constrained 
(23). Furthermore, although Patel and Kearney found that immu-
nization during the first few days after birth can alter B-1 cell 
repertoires, they found no evidence for alterations in the natural 
IgM serum pool (57), again suggesting that B-1 cell repertoires 
and natural IgM production are independently regulated and 
differentially affected by innate and antigen-induced signals.
CONCLUSiON
The heterogeneity of the B-1 cell precursors, including extra-
hematopoietic origins, ontogenetic, and tissue-specific effects, 
that seem to act on these cells and the high degree of functional 
plasticity and ability to respond to self- and inflammatory 
signals generates a diverse set of B-1 cells. Some have effector 
functions such as IgM secretion or cytokine production. Others, 
particularly those in the body cavities, appear to be poised to 
function a natural memory compartment and rapid response 
system that responds to innate signals with rapid relocation and 
differentiation.
There are some striking similarities between B-1 cells and 
macrophages in terms of their developmental origins and effec-
tor functions. Not because of a shared ontogeny or phenotype, 
but rather because of their ontogenic and functional plasticity. 
Macrophages and B-1 cells both develop in waves from extra-
hematopoietic and hematopoietic stem cell precursors (21). They 
both seed various tissues and differentiate based, at least in part, 
in response to tissue-specific signals (85). Whether some B-1 cells 
may also differentiate to become tissue restricted, such as micro-
glia, alveolar macrophages, or other tissue-specific macrophages, 
remains to be studied. Both cell types also respond rapidly to 
innate signals with relocation and on-site differentiation. And 
finally, both cell types fulfill important “housekeeping functions,” 
in order to maintain tissue homeostasis and to facilitate tissue 
repair (86). A better understanding of the plasticity and the het-
erogeneity among B-1 cells will be crucial to better understand 
the principles underlying their functions and responses.
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